Prepare with focused DHA Clinical Pharmacist exam mcqs covering the areas listed in the official DHA Prometric examination guideline. Practice Dubai Prometric Clinical Pharmacist Exam test under timed conditions, review detailed explanations, identify weak topics, and build confidence before exam day.
Start PracticePrometricDr's DHA Clinical Pharmacist practice test helps you assess your clinical knowledge across the major areas covered in the DHA Prometric examination. Practice exam style Dubai Prometric Clinical Pharmacist Exam multiple choice questions, review explanations, monitor your results, and use your performance to determine where further study is needed.
Best for candidates who are already preparing and want focused practice before exam day.
Ideal for candidates who want enough time to practice, review weak areas, and improve consistently.
Best for candidates who want maximum flexibility, long-term access, and plenty of time to prepare without rushing.
Whether you are starting your preparation or getting ready for another attempt, PrometricDr gives you a structured way to test your knowledge, strengthen weak areas, and build DHA Clinical Pharmacist exam readiness.
Candidates need a focused study approach that fits around their duties, personal commitments, and limited preparation time.
PrometricDr is designed to make DHA Prometric exam preparation more practical, structured, and consistent from your first study session through to exam day. This platform helps you maintain a clear study routine, stay engaged with relevant prep material, and approach your Dubai Prometric Clinical Pharmacist Exam with greater preparation and confidence.
Work through targeted Dubai Prometric Clinical Pharmacist Exam questions across important topics instead of spending time on random material.
Work through timed DHA Clinical Pharmacist practice test to improve pacing, concentration, and question management.
See your results immediately, review explanations, and discover which areas need more attention before your next attempt.
Doctors Prepared
Mock Tests Available
Specialties Covered
Exam Focused Accuracy
The Dubai Health Authority administers this specialist licensing examination for advanced pharmacy professionals (PharmD, M.Pharm, or residency-trained clinical pharmacists) looking to practice in inpatient hospital wards, ambulatory care clinics, and specialized critical care units in Dubai. Unlike the general retail pharmacist test, this exam focuses heavily on inpatient pharmacotherapy, therapeutic drug monitoring (TDM), antimicrobial stewardship, individualized dosing adjustments for organ clearance failure, and collaborative patient rounds. Candidates can book their testing appointment through Prometric after completing DataFlow primary source credential verification and receiving an approved eligibility reference via the DHA Sheryan portal.
|
Exam Parameter |
Details |
|
Exam Title |
Dubai Prometric Clinical Pharmacist Exam |
|
Authority |
Dubai Health Authority (DHA) |
|
Delivery Mode |
Prometric Computer-Based Test (CBT) |
|
Exam Code |
CPHAR / CLIN-PHARM |
|
Question Format |
Multiple-Choice (Single Best Answer) |
|
Number of MCQs |
150 questions |
|
Exam Duration |
2 hours 45 minutes to 3 hours (165 to 180 minutes) |
|
Passing Score |
65% |
|
Negative Marking |
None |
|
Language |
English |
|
Score Result |
Pass / Fail outcome posted directly to the Sheryan portal |
|
Score Validity |
5 years |
The examination syllabus assesses clinical pharmacotherapy, bedside drug therapy management, and complex clinical pharmacokinetics. Case vignettes test your ability to evaluate multi-drug regimens, detect contraindications in critically ill patients, resolve complex medication errors, and optimize evidence-based medical therapy.
|
Specialty Module |
Core Topics |
Key Focus Areas & Clinical Scenarios |
|
Cardiovascular & Hemodynamic Pharmacotherapy |
Acute coronary syndromes (ACS), acute decompensated heart failure, hypertensive crises, atrial fibrillation rate vs. rhythm control, and antiplatelet/anticoagulant selection (DAPT, DOACs, parenteral heparin bridging). |
Managing acute cardiogenic shock with inotropes and vasopressors, adjusting DOAC dosages based on renal CrCl and body weight, and monitoring antiarrhythmic toxicities (amiodarone, digoxin). |
|
Critical Care, Sepsis & Fluid Management |
Surviving Sepsis Campaign guidelines, vasopressor and inotropic support (norepinephrine, vasopressin, epinephrine), stress ulcer prophylaxis, delirium in the ICU (CAM-ICU), and crystalloid vs. colloid resuscitation. |
Titrating continuous sedation and analgesia infusions (propofol, dexmedetomidine, fentanyl), managing refractory septic shock, and selecting neuromuscular blockers with train-of-four monitoring in ARDS. |
|
Antimicrobial Stewardship & Infectious Diseases |
Empiric vs. targeted antimicrobial regimens, multi-drug resistant pathogens (MRSA, VRE, ESBL, CRE, Pseudomonas), antifungal selection, and viral infections. |
Step-down oral switch therapy, de-escalation protocols, beta-lactam extended infusion strategies, and designing combination regimens for carbapenem-resistant Enterobacterales. |
|
Clinical Pharmacokinetics & Therapeutic Drug Monitoring (TDM) |
Area under the curve (AUC) vs. trough dosing protocols (vancomycin), aminoglycosides once-daily vs. conventional dosing, phenytoin Michaelis-Menten kinetics, digoxin, and immunosuppressants. |
Calculating AUC24/MIC targets for vancomycin, adjusting phenytoin for hypoalbuminemia (Winter-Tozer equation), interpreting peak/trough blood levels, and resolving narrow therapeutic index drug toxicities. |
|
Renal, Hepatic & Endocrine Clinical Management |
Acute kidney injury (KDIGO criteria), continuous renal replacement therapy (CRRT) drug dosing, end-stage liver disease (Child-Pugh/MELD), and glycemic management in acute illness (DKA, HHS). |
Adjusting antibiotic and anticoagulant clearance during CVVH/CVVHD, managing hepatorenal syndrome pharmacotherapy, and converting complex IV regular insulin infusions to subcutaneous basal-bolus regimens. |
|
Oncology, Hematology & Supportive Care |
Chemotherapy-induced nausea and vomiting (CINV) prevention guidelines, febrile neutropenia empiric management, tumor lysis syndrome (TLS) prophylaxis and treatment (rasburicase), and pain protocols. |
Applying ASCO/NCCN antiemetic regimens (NK1 receptor antagonists, 5-HT3 antagonists, dexamethasone), managing chemotherapy extravasation protocols, and monitoring opioid rotations for cancer pain. |
|
Neurology & Psychiatric Pharmacotherapy |
Refractory status epilepticus protocols, acute ischemic stroke thrombolysis (alteplase/tenecteplase criteria), neuroleptic malignant syndrome (NMS), serotonin syndrome, and bipolar disorder pharmacotherapy. |
Rapid seizure abortive drug sequencing, recognizing life-threatening drug-drug interactions (MAOIs, SSRIs, SNRIs), and managing lithium toxicity and therapeutic drug levels. |
|
Parenteral Nutrition & Metabolic Support |
Total Parenteral Nutrition (TPN) macronutrient and micronutrient requirements, calcium-phosphate precipitation risks, electrolyte replacement protocols, and refeeding syndrome prevention. |
Designing custom TPN bags for catabolic ICU patients, managing severe hypophosphatemia/hypokalemia, calculating caloric requirements using indirect calorimetry, and line sepsis mitigation. |
|
Medication Safety, Pharmacovigilance & Toxicology |
Adverse Drug Reaction (ADR) reporting systems, Root Cause Analysis (RCA) for sentinel events, high-alert medications, antidote administration (digoxin Fab, lipid rescue, fomepizole), and drug shortages. |
Investigating near-miss look-alike sound-alike (LASA) dispensing errors, managing acute beta-blocker/calcium-channel blocker overdoses with high-dose insulin, and executing drug recalls. |
|
UAE Health Regulations, Controlled Drugs & Clinical Ethics |
DHA and MOHAP health authority guidelines, hospital formulary management (P&T committee roles), narcotic and semi-controlled drug custody rules, off-label drug approvals, and patient confidentiality. |
Implementing evidence-based formulary inclusions/exclusions, ensuring strict chain-of-custody for restricted ward stock narcotics, reviewing compassionate-use investigational drugs, and institutional review board (IRB) ethics. |
Copyright © 2026 PrometricDr. All Rights Reserved